Main pancreatic duct (MPD) dilation without an apparent obstructing lesion is an independent risk factor for neoplastic ...

Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced alignment with the U.S. Food and Drug ...

ImPact Biotech is an advanced clinical-stage oncology company focused on the development and commercialization of Padeliporfin Vascular Targeted Photodynamic (VTP) therapy, a minimally invasive ...

A Bolton nurse, from Wigan, has expressed gratitude to those who donated to support her during her breast cancer journey this year ...

Oncolytics Biotech ( ($ONCY) ) has shared an update. Oncolytics Biotech Inc. announced on November 19, 2025, that it has aligned with the FDA on ...

FN Media Group News Commentary - The precision oncology sector is experiencing unprecedented transformation as biomarker-driven therapies and platform immunotherapies reshape treatment paradigms for ...

Radiation therapy plays a vital role in breast cancer treatment. Get clear information on how it works, its benefits, and how ...

At ASCO 2025, several promising studies in pancreatic ductal adenocarcinoma (PDAC) were presented. In the neoadjuvant setting, the CASSANDRA trial compared the PAXG (nab-paclitaxel, capecitabine, ...